# Innoviva, Inc.: Form 8-K, filed Jul 11, 2023

- Company: [Innoviva, Inc.](/companies/inva.md) (CIK 1080014)
- Form: 8-K
- Filed: 2023-07-11
- Accepted by EDGAR: Jul 11, 2023, 08:16 ET
- Period: 2023-07-10
- Accession: 0001104659-23-079823
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1080014/000110465923079823/tm2320969d1_8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1080014/000110465923079823/

## Items reported

- Item 5.02: Departure or appointment of officers or directors
- Item 7.01: Regulation FD disclosure
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1080014/000110465923079823/tm2320969d1_8k.htm

Filed Jul 11, 2023.
Source: SEC EDGAR, the filing index for accession 0001104659-23-079823. Last ingested by Listed: Nov 4, 2026, 17:42 ET. No prices; not investment advice.